Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 29 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
PHARMA IMPEX from Les Bons Villers, company number BE0763508477, closed financial year 2024 with a result of € -3,218 after tax. For that financial year PHARMA IMPEX recorded a gross margin of € -5,736 and equity of € -13,123. Compared with financial year 2023, the result moved from € -5,960 to € -3,218. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2025.
€ -13,123
▼ € 3,218 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -3,218
▲ 46 % less loss than in 2023
Profit after tax over the fiscal year.
€ 33
▼ 95% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -15,123.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 6,277
▼ 58% vs 2023
Supplier invoices still open on the last day of the fiscal year.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 1,699 | € -6,575 | € -3,061 | € -5,736 | ▼ € 2,675 |
| Profit after taxes | € 1,260 | € -7,204 | € -5,960 | € -3,218 | ▲ € 2,741 |
| Equity | € 3,260 | € -3,944 | € -9,904 | € -13,123 | ▼ € 3,218 |
| Total debts | € 13,684 | € 11,985 | € 24,263 | € 22,340 | ▼ 8% |
| Cash | € 3,631 | € 1,214 | € 679 | € 33 | ▼ 95% |
| Retained profit | € 1,260 | € -5,944 | € -11,904 | € -15,123 | ▼ € 3,218 |
| Balance sheet total | € 16,945 | € 8,040 | € 14,359 | € 9,218 | ▼ 36% |
Key figures of PHARMA IMPEX, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PHARMA IMPEX?
What happened at PHARMA IMPEX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 3,218. filed late Source: NBB ↗
- Florian Langer became a director. NBB
- New establishment in Les Bons Villers. KBO
- Start of the company according to the CBE. KBO
- Eglantine Verheyen became a director. NBB
In short
From € 1,260 profit in 2021 to € 3,218 loss in 2024.
Paid € 353 in corporate taxes since 2021.
Best year ever: 2021, with € 1,260 profit.
Management
Behind PHARMA IMPEX are Florian Langer and Eglantine Verheyen.
Directors
According to the 2024 annual accounts
Florian Langer
Director
since 2023
Eglantine Verheyen
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Chaussée de Bruxelles(MEL) 101
6211 Les Bons Villers
Chaussée de Bruxelles(FLG) 101
6210 Les Bons Villers
Active since 11 February 2021
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0763.508.477
- VAT number
- BE 0763.508.477
- Registered office
- Chaussée de Bruxelles(MEL) 101, 6211 Les Bons Villers
- Names & denominations
- PHARMA IMPEX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 February 2021
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Handelsbemiddeling in de groothandel in andere specifieke goederen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Groothandel in andere machines en werktuigen, neg
Groothandel in andere machines en werktuigen, n.e.g.
Overige gespecialiseerde wetenschappelijke en technische activiteiten